Franck Charles Marie Grimaud is a businessperson who founded Vivalis SA and who has been the head of 6 different companies. Presently, he is Director & Managing Director at Vaccines Holdings Sweden AB, Co-President & Chief Business Officer at Valneva SE, Chairman at Vivalis Toyama Japan KK, Managing Director at Valneva Austria GmbH and Director & Deputy Chief Executive Officer at Intercell USA, Inc. (which are all subsidiaries of Valneva SE) and Director & President at Valneva Canada, Inc.
He is also Managing Director at Valneva Austria GmbH, Vice President-Competitiveness at Atlantic Biotherapies and Chief Business Officer of Intercell Austria AG and on the board of 6 other companies.
Mr. Grimaud previously held the position of President & Managing Director at Smol Therapeutics SAS and President & Chief Executive Officer at Vivalis SA.
He received an MBA from the University of Ottawa.